PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD62L, 25 μg
PE/Dazzle™ 594 anti-mouse CD63, 100 μg
PE/Dazzle™ 594 anti-mouse CD63, 25 μg
PE/Dazzle™ 594 anti-mouse CD64 (FcγRI), 100 μg
PE/Dazzle™ 594 anti-mouse CD64 (FcγRI), 25 μg
PE/Dazzle™ 594 anti-mouse CD69, 100 μg
PE/Dazzle™ 594 anti-mouse CD69, 25 μg
PE/Dazzle™ 594 anti-mouse CD80, 100 μg
PE/Dazzle™ 594 anti-mouse CD80, 25 μg
PE/Dazzle™ 594 anti-mouse CD86, 100 μg
PE/Dazzle™ 594 anti-mouse CD86, 25 μg
PE/Dazzle™ 594 anti-mouse CD8a, 100 μg
PE/Dazzle™ 594 anti-mouse CD8a, 25 μg
PE/Dazzle™ 594 anti-mouse CD8b (Ly-3), 100 μg
PE/Dazzle™ 594 anti-mouse CD8b (Ly-3), 25 μg
PE/Dazzle™ 594 anti-mouse CD90.2 (Thy1.2), 100 μg